Abstract:A 34-year-old Chinese woman was referred to our hospital at 24 weeks of gestation for persistent hypokalaemia and new onset of hypertension. Prior to pregnancy, she had a three-year history of recurrent episodes of muscle weakness and found to have low potassium levels (the lowest level was 1.8 mmol/L, normal 3.5–5.3 mmol/L). During the clinical visits, her blood pressure was normal, consistently 110–120/70–80 mmHg, until the twenty-third week of pregnancy, when it was found to be 160/100 mmHg. During her hospitalisation, blood pressure remained elevated despite treatment, with a peak level of 210/130 mmHg. Diagnostic evaluation included potassium levels, which remained low at 2.94–3.65 mmol/L despite supplementation; urinary protein was 1.98 g/24 h; urinary potassium excretion was 48 mmol/24 h, suggesting renal loss of potassium. The plasma renin activity (PRA) was 0.76 ng/mL/h (normal 0.2–1.9 ng/mL/h in non-pregnancy); plasma aldosterone concentration (PAC) was 830 pg/mL (normal 21–136 pg/mL in non-pregnancy), with a PAC-to-PRA ratio of 109. Urine catecholamines, plasma corticotrophin, cortisol and calcium concentrations were almost normal. Ultrasound scan identified a parenchymatous mass in the left adrenal gland. Primary aldosteronism was suspected, but surgery during pregnancy was not considered due to lack of expertise in this setting, though laparoscopic adrenalectomy during pregnancy might be a possible choice for treatment. Conservative treatment was adopted to prolong the pregnancy as much as possible, including nitroglycerin, nifedipine, labetabol, furosemide, magnesium sulfate, potassium supplement and other supportive therapies. Spironolactone was not adopted considering its uncertain effect to the fetus, although there was a report of it being used safely at high dose in a mother with Batter’s syndrome for two pregnancies without evidence of harm to male infants. Emergency caesarean section was performed at the twenty-fifth week of gestation because of HELLP syndrome (type III), uncontrolled hypertension and mild placental abruption. Her blood pressure decreased after delivery but not to normal. Abdominal computed tomography six months later confirmed a tumour in the left adrenal gland (Fig. 1). Laparoscopic adrenalectomy was then performed and pathological analysis confirmed a cortical adenoma of the left adrenal gland. After surgery, her serum potassium level and blood pressure gradually returned to normal. PRA, PAC and PAC-to-PRA ratio all returned to normal after three months. On follow up, serum potassium levels and blood pressure have remained normal without medication. This patient was not hypertensive in early pregnancy, most probably due to the physiological vasodilation that occurs in pregnancy. Hypertension due to Conn’s may not become apparent until midto late pregnancy (as occurred for this patient) or until post-partum. Persistent hypokalaemia, with increased potassium loss in urine, as occurred in this case, Correspondence: Professor Hong Li, 3 East Qingchun Road, Sir Run Run Shaw Hospital, Hangzhou 310016, China. Email: lihongheyi@126.com

Changes in echocardiography and blood variables during and after development of Ballantyne syndrome

Angiotensin Receptor Agonistic Autoantibody-Mediated Tumor Necrosis Factor-Alpha Induction Contributes To Increased Soluble Endoglin Production In Preeclampsia

[Ballantyne syndrome associated with fetal cardiac rhabdomyoma: a case report]

Mirroring preeclampsia: the molecular basis of Ballantyne syndrome

Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy

Primary Aldosteronism and Pregnancy: A Case Report

Use of Ballistocardiography to Monitor Cardiovascular Hemodynamics in Preeclampsia

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

P182 AORTIC VASCULAR BIOMARKERS FOR THE EARLY DETECTION OF PLACENTAL SYNDROMES DURING PREGNANCY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Angiogenic Factors During Pregnancy in Asian Women with Elevated Blood Pressure in Early Pregnancy and the Risk of Preeclampsia: a Longitudinal Cohort Study

Changes of serum cardiotropin I and cystatin C in preeclampsia and significance thereof

Echocardiographic Assessments for Peripartum Cardiac Events in Pregnant Women with Low-Risk Congenital Heart Disease

Maternal cardiovascular function at mid‐gestation is related to placental angiogenesis

Alterations in maternal cardiovascular parameters and their impact on uterine and fetal circulation in hypertensive pregnancies and fetal growth restriction

Significant Clinical Manifestations in Ballantyne Syndrome, after a Case Report and Literature Review: Recognizing Preeclampsia as a Differential Diagnosis

Association of Perinatal Cardiovascular Features with Angiotensin System Expressions in Maternal Preeclampsia

A longitudinal study on the effect of obesity upon circulating renin-angiotensin system in normal pregnancy

Acute Cardiac Effects of Severe Pre-Eclampsia

Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia

Soluble Fms-Like Tyrosine Kinase 1 and Soluble Endoglin Are Elevated Circulating Anti-Angiogenic Factors in Pre-Eclampsia.

Cardiac function in pregnant women with preeclampsia